Skip to main content

4 Result(s)

within Dirk Arnold Remove this filter Radiotherapy Remove this filter

and

  1. No Access

    Article

    Arbeitsgruppen zu kolorektalen Tumoren der AIO, der ACO und der ARO – „past, present, and future“

    Prof. Dr. med. Ralf Hofheinz, Dirk Arnold, Stefan Fichtner-Feigl… in Der Onkologe (2022)

  2. Article

    Open Access

    Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer

    Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (p...

    Kathrin Dellas, Thomas Höhler, Thomas Reese, Florian Würschmidt… in Radiation Oncology (2013)

    Download PDF (389 KB) View Article

  3. Article

    Open Access

    Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study

    Local control appears to be an important treatment aim in patients with limited metastases (oligometastases) of colorectal cancer (CRC). Those patients show a favourable prognosis, if - in addition to the loca...

    Kathrin Dellas, Thomas Reese, Michael Richter, Dirk Arnold… in Radiation Oncology (2012)

    Download PDF (244 KB) View Article

  4. No Access

    Article

    Induction Chemotherapy before Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer

    In the era of preoperative chemoradiotherapy (CRT) and total mesorectal excision (TME), the development of distant metastases is the predominant mode of failure in rectal cancer patients today. Integrating mor...

    Claus Rödel MD, Dirk Arnold, Heinz Becker, Rainer Fietkau… in Strahlentherapie und Onkologie (2010)